富士製薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/11/18 | 1,017 | 1,023 | 1,014 | 1,014 | ±0 | ±0% | 33,600 |
| 2022/11/17 | 1,002 | 1,014 | 1,002 | 1,014 | +9 | +0.9% | 22,200 |
| 2022/11/16 | 1,008 | 1,011 | 1,004 | 1,005 | -7 | -0.7% | 29,100 |
| 2022/11/15 | 1,004 | 1,017 | 1,004 | 1,012 | +1 | +0.1% | 37,300 |
| 2022/11/14 | 1,035 | 1,036 | 1,005 | 1,011 | -27 | -2.6% | 84,000 |
| 2022/11/11 | 1,087 | 1,087 | 1,033 | 1,038 | -40 | -3.7% | 114,300 |
| 2022/11/10 | 1,070 | 1,079 | 1,064 | 1,078 | +8 | +0.7% | 29,500 |
| 2022/11/09 | 1,070 | 1,080 | 1,063 | 1,070 | +5 | +0.5% | 41,000 |
| 2022/11/08 | 1,072 | 1,075 | 1,060 | 1,065 | -7 | -0.7% | 27,800 |
| 2022/11/07 | 1,082 | 1,084 | 1,062 | 1,072 | +5 | +0.5% | 35,100 |
| 2022/11/04 | 1,084 | 1,089 | 1,067 | 1,067 | -17 | -1.6% | 63,900 |
| 2022/11/02 | 1,051 | 1,084 | 1,044 | 1,084 | +33 | +3.1% | 123,300 |
| 2022/11/01 | 1,074 | 1,074 | 1,043 | 1,051 | -20 | -1.9% | 52,700 |
| 2022/10/31 | 1,079 | 1,082 | 1,058 | 1,071 | +11 | +1% | 59,900 |
| 2022/10/28 | 1,045 | 1,067 | 1,044 | 1,060 | +11 | +1% | 119,800 |
| 2022/10/27 | 1,042 | 1,050 | 1,034 | 1,049 | +5 | +0.5% | 20,000 |
| 2022/10/26 | 1,038 | 1,045 | 1,034 | 1,044 | +10 | +1% | 17,500 |
| 2022/10/25 | 1,042 | 1,042 | 1,028 | 1,034 | -4 | -0.4% | 16,000 |
| 2022/10/24 | 1,047 | 1,048 | 1,033 | 1,038 | +5 | +0.5% | 21,500 |
| 2022/10/21 | 1,032 | 1,035 | 1,021 | 1,033 | -6 | -0.6% | 21,000 |
| 2022/10/20 | 1,032 | 1,039 | 1,022 | 1,039 | -4 | -0.4% | 42,800 |
| 2022/10/19 | 1,038 | 1,045 | 1,038 | 1,043 | +6 | +0.6% | 12,900 |
| 2022/10/18 | 1,031 | 1,037 | 1,028 | 1,037 | +13 | +1.3% | 16,200 |
| 2022/10/17 | 1,032 | 1,034 | 1,022 | 1,024 | -11 | -1.1% | 20,600 |
| 2022/10/14 | 1,029 | 1,044 | 1,029 | 1,035 | +13 | +1.3% | 43,000 |
| 2022/10/13 | 1,024 | 1,027 | 1,018 | 1,022 | -2 | -0.2% | 21,700 |
| 2022/10/12 | 1,015 | 1,033 | 1,013 | 1,024 | +8 | +0.8% | 28,700 |
| 2022/10/11 | 1,026 | 1,032 | 1,016 | 1,016 | -17 | -1.6% | 35,300 |
| 2022/10/07 | 1,028 | 1,046 | 1,028 | 1,033 | -3 | -0.3% | 39,600 |
| 2022/10/06 | 1,031 | 1,045 | 1,031 | 1,036 | +7 | +0.7% | 30,500 |
| 2022/10/05 | 1,033 | 1,033 | 1,016 | 1,029 | -4 | -0.4% | 21,200 |
| 2022/10/04 | 1,030 | 1,033 | 1,018 | 1,033 | +15 | +1.5% | 31,000 |
| 2022/10/03 | 1,030 | 1,030 | 1,011 | 1,018 | -16 | -1.5% | 32,300 |
| 2022/09/30 | 1,033 | 1,050 | 1,032 | 1,034 | ±0 | ±0% | 54,200 |
| 2022/09/29 | 1,030 | 1,040 | 995 | 1,034 | +4 | +0.4% | 49,700 |
| 2022/09/28 | 1,015 | 1,030 | 1,012 | 1,030 | +13 | +1.3% | 39,100 |
| 2022/09/27 | 1,029 | 1,029 | 1,017 | 1,017 | -3 | -0.3% | 32,900 |
| 2022/09/26 | 1,028 | 1,028 | 1,011 | 1,020 | -10 | -1% | 58,800 |
| 2022/09/22 | 1,028 | 1,040 | 1,025 | 1,030 | -2 | -0.2% | 42,800 |
| 2022/09/21 | 1,028 | 1,034 | 1,026 | 1,032 | -5 | -0.5% | 23,300 |
| 2022/09/20 | 1,036 | 1,040 | 1,024 | 1,037 | -3 | -0.3% | 56,100 |
| 2022/09/16 | 1,007 | 1,040 | 1,006 | 1,040 | +33 | +3.3% | 72,900 |
| 2022/09/15 | 1,014 | 1,016 | 1,007 | 1,007 | -7 | -0.7% | 15,500 |
| 2022/09/14 | 1,015 | 1,022 | 1,005 | 1,014 | -11 | -1.1% | 22,700 |
| 2022/09/13 | 1,024 | 1,028 | 1,020 | 1,025 | +3 | +0.3% | 22,900 |
| 2022/09/12 | 1,017 | 1,026 | 1,017 | 1,022 | +5 | +0.5% | 22,900 |
| 2022/09/09 | 1,000 | 1,021 | 1,000 | 1,017 | +17 | +1.7% | 46,300 |
| 2022/09/08 | 998 | 1,003 | 994 | 1,000 | +6 | +0.6% | 29,000 |
| 2022/09/07 | 999 | 1,000 | 989 | 994 | -3 | -0.3% | 26,300 |
| 2022/09/06 | 1,008 | 1,012 | 997 | 997 | -18 | -1.8% | 37,600 |
601～
650
件表示中 / 6945件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 富士製薬 | 136,100円 | +15.7% | +5.3% | 3.34% | 9.84倍 | 0.73倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| タウンズ | 50,200円 | +4.6% | +6.1% | 5.58% | 8.54倍 | 3.16倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
| 生化学 | 70,700円 | +9.2% | +39.0% | 4.24% | 23.39倍 | 0.51倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| ヘリオス | 32,300円 | +150.0% | - | 0.00% | - | 15.89倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| ダイト | 209,600円 | +4.5% | -33.7% | 3.34% | 21.11倍 | 0.61倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
市場注目の銘柄
チャート関連のコラム
